Transcriptional regulation of Smad2 is required for enhancement of TGFβ/Smad signaling by TGFβ inducible early gene

Journal of Cellular Biochemistry

Volumn 87, Issue 2, 2002, Pages 233-241

  Johnsen, Steven A ^a   Subramaniam, Malayannan ^a   Katagiri, Takenobu ^b   Janknecht, Ralf ^a   Spelsberg, Thomas C ^a  

^a MAYO CLINIC   (United States)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein (BMP); Kr ppel like factor (KLF); Smad; TGF inducible early gene (TIEG); Transforming growth factor (TGF )

Indexed keywords

BONE MORPHOGENETIC PROTEIN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; EMBRYO; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELLS, CULTURED; DNA-BINDING PROTEINS; EMBRYO; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC VECTORS; HUMANS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036384562     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10299     Document Type: Article

References (48)

1. Akhurst RJ, Derynck R. 2001. TGF-beta signaling in cancer-a double-edged sword. Trends Cell Biol 11: S44-S51.
2. Asano H, Li XS, Stamatoyannopoulos G. 2000. FKLF-2: A novel Kruppel-like transcriptional factor that activates globin and other erythroid lineage genes. Blood 95:3578-3584.
3. Blok LJ, Grossmann ME, Perry JE, Tindall DJ. 1995. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol 9:1610-1620.
4. Boyer PL, Colmenares C, Stavnezer E, Hughes SH. 1993. Sequence and biological activity of chicken snoN cDNA clones. Oncogene 8:457-466.
5. Casellas R, Brivanlou AH. 1998. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. Dev Biol 198:1-12.
6. Chalaux E, Lopez-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura F. 1999. A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial MvlLu cells. FEBS Lett 457:478-482.
7. Cook T, Gebelein B, Belal M, Mesa K, Urrutia R. 1999. Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily of Sp1-like zinc finger proteins. J Biol Chem 274:29500-29504.
8. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
9. Derynck R, Feng XH. 1997. TGF-beta receptor signaling. Biochim Biophys Acta 1333:F105-F150.
10. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276:12477-12480.
11. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
12. Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K. 1999. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondro-blast differentiation. Mol Biol Cell 10:3801-3813.
13. Goumans MJ, Mummery C. 2000. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44:253-265.
14. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA, Jr. Wrana JL, Falb D. 1997. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89:1165-1173.
15. Hefferan TE, Reinholz GG, Rickard DJ, Johnsen SA, Waters KM, Subramaniam M, Spelsberg TC. 2000. Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells. J Biol Chem 275:20255-20259.
16. Imataka H, Sogawa K, Yasumoto K, Kikuchi Y, Sasano K, Kobayashi A, Hayami M, Fujii-Kuriyama Y. 1992. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J 11:3663-3671.
17. Johnsen SA, Subramaniam M, Janknecht R, Spelsberg TC. 2002. TGFβ inducible early gene enhances TGFβ/Smad dependent transcriptional responses. Oncogene 21: 5783-5790.
18. Kaczynski J, Zhang JS, Ellenrieder V, Conley A, Duenes T, Kester H, van Der Burg B, Urrutia R. 2001. The Sp1-like protein BTEB3 inhibits transcription via the basic transcription element box by interacting with mSin3A and HDAC-1 co-repressors and competing with Sp1. J Biol Chem 276:36749-36756.
19. Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R. Identification of a BMP-responsive element in the Id1, the gene for inhibitor of myogenesis. Genes Cells, In press.
20. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6:1365-1375.
21. Kleeff J, Friess H, Simon P, Susmallian S, Buchler P, Zimmermann A, Buchler MW, Korc M. 1999a. Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer. Dig Dis Sci 44:1793-1802.
22. Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Buchler MW, Falb D, Korc M. 1999b. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18:5363-5372.
23. Kleeff J, Maruyama H, Friess H, Buchler MW, Falb D, Korc M. 1999c. Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. Biochem Biophys Res Commun 255:268-273.
24. Koli KM, Arteaga CL. 1996. Complex role of tumor cell transforming growth factor (TGF)-beta on breast carcinoma progression. J Mammary Gland Biol. Neoplasia 1:373-380.
25. Korchynskyi O, ten Dijke P. 2002. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277:4883-4891.
26. Lopez-Rovira T, Chalaux E, Massague J, Rosa JL, Ventura F. 2002. Direct binding of Smadl and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J Biol Chem 277:3176-3185.
27. Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S, Zhou Q. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev 13:2196-2206.
28. Massague J, Blain SW, Lo RS. 2000. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
29. Miyazono K. 2000. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev 11:15-22.
30. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P. 1997. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389:631-635.
31. Osaki M, Tsukazaki T, Ono N, Yonekura A, Hirota Y, Miyazaki Y, Shindo H, Sonta S, Yamashita S. 1999. cDNA cloning and chromosomal mapping of rat Smad2 and Smad4 and their expression in cultured rat articular chondrocytes. Endocr J 46:695-701.
32. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB. 2001. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 276:19945-19953.
33. Pouliot F, Labrie C. 1999. Expression profile of agonistic Smads in human breast cancer cells: Absence of regulation by estrogens. Int J Cancer 81:98-103.
34. Ribeiro A, Bronk SF, Roberts PJ, Urrutia R, Gores GJ. 1999. The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology 30:1490-1497.
35. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. 1996. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 11:312-324.
36. Song A, Chen YF, Thamatrakoln K, Storm TA, Krensky AM. 1999. RFLAT-1: A new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 10:93-103.
37. Song CZ, Keller K, Murata K, Asano H, Stamatoyannopoulos G. 2002. Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2. J Biol Chem 277:7029-7036.
38. Souchelnytskyi S, Nakayama T, Nakao A, Moren A, Heldin CH, Christian JL, ten Dijke P. 1998. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. J Biol Chem 273:25364-25370.
39. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. 1995. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 23: 4907-4912.
40. Subramaniam M, Hefferan TE, Tau K, Peus D, Pittelkow M, Jalal S, Riggs BL, Roche P, Spelsberg TC. 1998. Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J Cell Biochem 68:226-236.
41. Tachibana I, Imoto M, Adjei PN, Gores GJ, Subramaniam M, Spelsberg TC, Urrutia R. 1997. Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 99:2365-2374.
42. Takase M, Imamura T, Sampath TK, Takeda K, Ichijo H, Miyazono K, Kawabata M. 1998. Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem Biophys Res Commun 244:26-29.
43. Takenoshita S, Mogi A, Nagashima M, Yang K, Yagi K, Hanyu A, Nagamachi Y, Miyazono K, Hagiwara K. 1998. Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway. Genomics 48:1-11.
44. ten Dijke P, Miyazono K, Heldin CH. 2000. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci 25:64-70.
45. Wieser R, Wrana JL, Massague J. 1995. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J 14:2199-2208.
46. Yajima S, Lammers CH, Lee SH, Hara Y, Mizuno K, Mouradian MM. 1997. Cloning and characterization of murine glial cell-derived neurotrophic factor inducible transcription factor (MGIF). J Neurosci 17: 8657-8666.
47. Zhang JS, Moncrieffe MC, Kaczynski J, Ellenrieder V, Prendergast FG, Urrutia R. 2001. A conserved alphahelical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol Cell Biol 21:5041-5049.
48. Zhu Y, Richardson JA, Parada LF, Graff JM. 1998. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703-714.